Infinity-Swedeheart Registry Based Randomized Clinical Trial (R-RCT)

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 2400 participants.

Also called NCT04562805

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 2,400 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04562805
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Sweden (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT04562805. Randomized; single masking; primary purpose treatment. Start 2020-09-30 (actual); primary completion 2024-09-05 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Infinity-Swedeheart Registry Based Randomized Clinical Trial (R-RCT)
Condition
Ischemic Heart Disease
Intervention (Device)
DynamX Bioadaptor
Intervention (Device)
Resolute Onyx
Lead sponsor
Elixir Medical Corporation (class: industry)
Collaborator
Uppsala University (class: other)

Record details

Record id
cardio:ct-nct04562805
Content hash
cbd46e1c7588e131e905ca37ec467928087057e4840d99cee454d76f71173df5